An open-label, randomized, crossover study to estimate the formulation effect on the relative bioavailability of single dose oral SB-742510 in healthy subjects.
Phase of Trial: Phase I
Latest Information Update: 20 Apr 2008
At a glance
- Drugs SB 742510 (Primary)
- Indications Bacterial infections
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 20 Apr 2008 Status changed from in progress to completed
- 21 Mar 2007 New trial record.